1st Counsel – Lifestyle
Author:
Neuronetics
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 29, 2026
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
April 21, 2026
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
April 13, 2026
Neuronetics Comments on Letter from Pointillist Family Office
April 7, 2026
Neuronetics Announces Chief Financial Officer Transition
April 6, 2026
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
March 17, 2026